封面
市場調查報告書
商品編碼
1630720

藥物依從性市場規模、佔有率、成長分析,按產品類型、按劑量類型、按交付方式、按最終用戶、按地區 - 行業預測,2025 年至 2032 年

Medication Adherence Market Size, Share, Growth Analysis, By Product Type (Hardware, Software), By Medication Type (Cardiovascular Drugs, Diabetes Drugs), By Delivery Mode, By End-User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計 2023 年藥物依從性市場規模將達到 45 億美元,並從 2024 年的 52 億美元成長到 2032 年的 164.6 億美元,預測期內(2025-2032 年)的複合年成長率為 15.5%。

全球藥物依從性市場正在經歷顯著擴張,這得益於對以患者為中心的護理的日益關注、慢性病患病率的上升以及醫療技術的進步。持續存在的服藥依從性差的挑戰會導致治療效果不佳和醫療成本高昂。為了解決這一重大問題,越來越多旨在提高藥物依從率的創新解決方案和技術正在出現。這種積極主動的方法不僅可以解決依從性難題,還可以推動全球藥物依從性市場的整體成長,預示著患者參與度和健康狀況的提高的美好未來。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 次要和資料資料
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024 年)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 監管格局
  • 專利分析

藥物依從性市場規模(依產品類型)

  • 市場概況
  • 硬體
    • 智慧藥瓶
    • 智慧錠劑分配器
    • 電子藥品包
  • 軟體
    • 藥物管理應用程式
    • 電子健康記錄 (EHR) 整合
  • 服務
    • 藥物治療管理
    • 病患教育和培訓

藥物依從性市場規模(依藥物類型)

  • 市場概況
  • 心血管藥物
  • 糖尿病藥物
  • 呼吸系統藥物
  • 中樞神經系統 (CNS) 藥物
  • 腫瘤藥物
  • 其他

藥物依從性市場規模(以交付方式)

  • 市場概況
  • 本地
  • 雲端基礎

藥物依從性市場規模(以最終用戶分類)

  • 市場概況
  • 醫院
  • 藥局
  • 家庭醫療保健
  • 研究組織
  • 其他

藥物依從性市場規模

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前 5 家公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採用的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024 年)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分析市場佔有率
    • 收益與前一年同期比較(2022-2024 年)

主要企業簡介

  • Omnicell, Inc.(United States)
  • Koninklijke Philips NV(Netherlands)
  • Medtronic plc(Ireland)
  • McKesson Corporation(United States)
  • Cerner Corporation(United States)
  • Becton, Dickinson and Company(United States)
  • Johnson & Johnson Services, Inc.(United States)
  • Novartis International AG(Switzerland)
  • Siemens Healthineers AG(Germany)
  • AdhereTech Inc.(United States)
  • SMRxT Inc.(United States)
  • Pillsy Inc.(United States)
  • TruMed Systems Inc.(United States)
  • Proteus Digital Health(United States)
  • Allscripts Healthcare Solutions, Inc.(United States)
  • MedMinder(United States)
  • Caredose(United States)
  • PHC Holdings Corporation(Japan)
  • Kakehashi Inc.(Japan)

結論和建議

簡介目錄
Product Code: SQMIG35F2015

Global Medication Adherence Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 5.2 billion in 2024 to USD 16.46 billion by 2032, growing at a CAGR of 15.5% during the forecast period (2025-2032).

The global medication adherence market is experiencing significant expansion, fueled by a heightened emphasis on patient-centric care, a growing incidence of chronic diseases, and advancements in healthcare technology. The ongoing challenge of poor medication adherence has resulted in ineffective treatment outcomes and escalating healthcare costs. In response to this critical issue, an array of innovative solutions and technologies has emerged, aimed at enhancing medication adherence rates. This proactive approach not only addresses the adherence dilemma but also propels the overall growth of the global medication adherence market, indicating a promising future driven by patient engagement and improved health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medication Adherence market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medication Adherence Market Segmental Analysis

Global Medication Adherence Market is segmented by Product Type, Medication Type, Delivery Mode, End-User and region. Based on Product Type, the market is segmented into Hardware, Software and Services. Based on Medication Type, the market is segmented into Cardiovascular Drugs, Diabetes Drugs, Respiratory Drugs, Central Nervous System (CNS) Drugs, Oncology Drugs and Others. Based on Delivery Mode, the market is segmented into On-Premise and Cloud-Based. Based on End-User, the market is segmented into Hospitals, Pharmacies, Home Healthcare, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Medication Adherence Market

The Global Medication Adherence market is being significantly propelled by the rising burden of chronic diseases, including diabetes, cardiovascular conditions, respiratory disorders, and cancer. As these conditions become more prevalent, the need for effective long-term medication adherence strategies intensifies to ensure optimal treatment outcomes and enhance patient health. The aging population, which is particularly vulnerable to chronic illnesses and often requires multiple medications for effective disease management, further amplifies this demand. Medication adherence solutions are essential in assisting older adults in managing their medication schedules effectively, thereby reducing the risk of complications associated with improper medication use and improving overall health outcomes.

Restraints in the Global Medication Adherence Market

The Global Medication Adherence market faces significant restraints, particularly due to apprehensions surrounding privacy and data security. With the increasing integration of digital health technologies in medication adherence solutions, there are growing concerns regarding the safeguarding of patient information. Healthcare providers and solution developers must prioritize these issues, as they are crucial for fostering trust and maintaining patient confidentiality. Addressing these concerns is essential to ensure the successful implementation and adoption of medication adherence solutions, as any breach or perception of insecurity could hinder market growth and patient cooperation in adhering to treatment plans.

Market Trends of the Global Medication Adherence Market

The Global Medication Adherence market is experiencing a notable trend towards remote patient monitoring, driven by the surge in telehealth services. The COVID-19 pandemic accelerated the adoption of virtual healthcare, making it crucial for healthcare providers to ensure patient compliance with medication regimens. Advanced technologies, including mobile apps and wearables, enable healthcare professionals to monitor adherence in real-time and deliver timely interventions or reminders, thereby enhancing patient outcomes. As healthcare systems increasingly prioritize patient engagement and outcomes, the integration of remote monitoring solutions is expected to reshape the medication adherence landscape, fostering a more proactive and personalized approach to patient care.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Medication Adherence Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Hardware
    • Smart Pill Bottles
    • Smart Pill Dispensers
    • Electronic Medication Packaging
  • Software
    • Medication Management Apps
    • Electronic Health Records (EHR) Integration
  • Services
    • Medication Therapy Management
    • Patient Education & Training

Global Medication Adherence Market Size by Medication Type & CAGR (2025-2032)

  • Market Overview
  • Cardiovascular Drugs
  • Diabetes Drugs
  • Respiratory Drugs
  • Central Nervous System (CNS) Drugs
  • Oncology Drugs
  • Others

Global Medication Adherence Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • On-Premise
  • Cloud-Based

Global Medication Adherence Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Pharmacies
  • Home Healthcare
  • Research Institutes
  • Others

Global Medication Adherence Market Size & CAGR (2025-2032)

  • North America (Product Type, Medication Type, Delivery Mode, End-User)
    • US
    • Canada
  • Europe (Product Type, Medication Type, Delivery Mode, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Medication Type, Delivery Mode, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Medication Type, Delivery Mode, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Medication Type, Delivery Mode, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Omnicell, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Services, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis International AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AdhereTech Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SMRxT Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pillsy Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TruMed Systems Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteus Digital Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allscripts Healthcare Solutions, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedMinder (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caredose (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PHC Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kakehashi Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations